Astrotech Q1 Loss Narrows to $2.9M as OpEx Falls 15.7%

Astrotech Corporation (Nasdaq: ASTC) reported a net loss of $2.9 million, or $1.46 per basic and diluted share, for its first quarter of fiscal 2027 ended September 30, 2026, the company announced on November 13, 2026. The result narrowed from a $3.5 million net loss, or $2.07 per share, in the same quarter a year earlier. Revenue slipped to $274 thousand from $297 thousand, while total operating expenses fell 15.7% to $3.1 million from $3.7 million.

Context — why Astrotech's shrinking cash pile matters now

Astrotech's first-quarter filing lands with the company's cash position as the central question. Cash and cash equivalents stood at $5.6 million on September 30, 2026, down from $8.4 million on June 30, 2026. Short-term investments added $2.9 million, leaving total liquid resources of roughly $8.5 million against a quarterly operating loss of $3.0 million.

The company's own release frames the quarter around discipline. "Our first-quarter results reflect the dedication of our team and executing against our strategic priorities," said Thomas B. Pickens, III, Astrotech's Chairman, Chief Executive Officer and Chief Technology Officer. The company said it remains focused on disciplined execution and investing in opportunities that strengthen its business.

The comparable the report itself supplies is the prior-year quarter. Operating expenses dropped from $3.7 million to $3.1 million, and the net loss narrowed by $517 thousand. Gross profit, however, fell to $102 thousand from $188 thousand, because cost of revenue rose to $172 thousand from $109 thousand while revenue declined.

What changed inside the expense line is the composition. Research and development spending fell to $1.0 million from $1.9 million, a cut of roughly 47%. Selling, general and administrative costs rose to $2.1 million from $1.8 million. The company did not explain the shift in the release.

Working capital was $11.6 million as of September 30, 2026. That figure, not the cash balance alone, is the number the company chose to highlight as supporting ongoing operations and strategic priorities.

The macro backdrop is not addressed in the report. No interest rate, index level or sector benchmark is cited.

Data — what Astrotech's Q1 FY2027 numbers show

Metric	Q1 FY2027	Q1 FY2026
Revenue	$274K	$297K
Gross profit	$102K	$188K
Total operating expenses	$3,141K	$3,724K
Loss from operations	$(3,039)K	$(3,536)K
Net loss	$(2,948)K	$(3,465)K
Net loss per share	$(1.46)	$(2.07)
Weighted average shares	2,021K	1,673K

Revenue fell 7.7% year over year. Cost of revenue rose 57.8%, from $109 thousand to $172 thousand, which compressed gross margin to 37.2% from 63.3%. The company did not break out revenue by subsidiary or segment.

Total assets declined to $17.8 million from $20.5 million at June 30, 2026. Total stockholders' equity fell to $13.9 million from $16.2 million, tracking the quarterly loss and a $92 thousand unrealized loss on available-for-sale securities. Total liabilities fell to $3.9 million from $4.3 million.

Shares issued rose to 2,118,891 at September 30, 2026 from 2,009,050 at June 30, 2026. Additional paid-in capital rose to $92.0 million from $91.3 million, implying roughly $778 thousand of equity issuance during the quarter. The company did not state the terms of that issuance in the release.

Inventory composition shifted sharply. Work-in-process jumped to $305 thousand from $9 thousand, while raw materials fell to $2.8 million from $2.9 million. Finished goods were roughly flat at $1.1 million. The company offered no explanation for the build.

No peer or sector comparison appears in the report.

Analysis — what the quarter signals for ASTC holders

The quarter's arithmetic is simple: Astrotech cut its operating loss by spending less on research and development while administrative costs grew. That is a mix shift, not an efficiency gain across the board. A company that trims R&D to slow cash burn is trading future product cadence for present runway.

The cash trajectory is the binding constraint. Liquid resources of roughly $8.5 million against a $3.0 million quarterly operating loss implies a runway measured in quarters, not years, before the company needs fresh capital. The share count rose during the quarter, and any further raise would dilute holders again.

The company's stated non-dilutive path runs through NASA. Astrotech said it submitted a proposal with Skycorp Incorporated under the NextSTEP-3 Lunar Enabling Infrastructure Accelerator program to advance its Mobile Power System from Technology Readiness Level 4 to TRL 6. The company said the project would deliver 6 kW of continuous power and 10 kW surge for lunar polar environments, culminating in an integrated system test at its Austin, Texas facility.

The company was explicit about the risk: it said there can be no assurance NASA will select the project for funding. That sentence is the honest disclosure in the release, and it should anchor any read of the lunar story.

The counter-argument is that TRACER 1000 deployment is the real commercial signal. The company said the detector is deployed in approximately 38 locations across 17 countries spanning the United States, Europe, Central America and Asia. That is a distribution footprint, but the release gives no revenue contribution from it, so the installed base cannot yet be tied to the income statement.

Positioning follows the cash line. Micro-cap holders are watching for any shelf or offering announcement, while the NASA decision is the binary event that could change the funding picture without dilution.

Outlook — what to watch for Astrotech

The next hard date is the company's second-quarter fiscal 2027 report, which would cover the period ending December 31, 2026. The company did not announce a date.

The NASA NextSTEP-3 selection timeline is the other catalyst. The company said the proposal was recently submitted and gave no decision date.

On the balance sheet, watch cash and cash equivalents against the $5.6 million reported at September 30, 2026. A further decline toward the $3 million mark would sharpen the runway question. Watch the share count as well: 2,118,891 shares issued at quarter-end versus 2,009,050 at June 30, 2026.

Watch gross margin. It fell to 37.2% from 63.3% year over year. A second consecutive quarter near that level would suggest the revenue mix has shifted structurally rather than quarter to quarter.

No support or resistance levels are cited in the report, and none are asserted here.

Frequently Asked Questions

What does Astrotech's Q1 FY2027 loss mean for retail investors?

It means the company spent $3.1 million to generate $274 thousand of revenue, leaving a $2.9 million net loss. The loss narrowed year over year because operating expenses fell, not because revenue grew. Revenue actually declined 7.7%. Retail holders should weigh the shrinking cash balance of $5.6 million against the quarterly burn rate, and note the company said working capital was $11.6 million.

Why did Astrotech's research and development costs fall so sharply?

Research and development fell to $1.0 million from $1.9 million a year earlier, a cut of roughly 47%. The company did not explain the decline in its release. The drop accounted for most of the $583 thousand reduction in total operating expenses, and it offset a $335 thousand increase in selling, general and administrative costs. The release offers no guidance on whether the lower R&D level persists.

What happens next for Astrotech stock?

The company's near-term funding hinges on two events it did not date: its fiscal second-quarter report and a NASA decision on the NextSTEP-3 LEIA proposal submitted with Skycorp. Astrotech said an award would provide needed non-dilutive capital, but also said there is no assurance NASA will select the project. Until either resolves, the cash balance and share count are the metrics that move the story.

Bottom Line

Astrotech cut its quarterly loss by spending less on R&D, but a $5.6 million cash balance keeps dilution risk live.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.